MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmjopen-2024-094887

Медицинская библиотека · BMJ open · 2025

Incidence of major adverse kidney events after ICU admission in COVID-19 and non-COVID-19 ARDS patients.

Alenezi Faraj K, Mahida Rahul Y, Bangash Mansoor N, Patel Jaimin, Thickett David, Parekh Dhruv

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

To compare the incidence and drivers of major adverse kidney events (MAKEs) between COVID-19 and non-COVID-19 acute respiratory distress syndrome (ARDS) patients, with a focus on long-term kidney outcomes.

DESIGN

Retrospective cohort study.

SETTING

Single-centre intensive care unit in the Midlands, UK.

PARTICIPANTS

708 ARDS patients (458 COVID-19, 250 non-COVID-19).

PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was MAKE at 365 days (MAKE-365), defined as new renal replacement therapy (RRT), estimated glomerular filtration rate (eGFR) <75% of baseline or all-cause mortality. Secondary analyses examined non-mortality MAKE components.

RESULTS

The incidence of MAKE-365 was significantly higher in the non-COVID-19 group compared with the COVID-19 group (66% vs 39%, p<0.001), primarily driven by increased RRT initiation, followed by mortality and eGFR decline (p=0.055). Independent predictors of MAKE-365 included lower eGFR and elevated bilirubin in both groups. Age (p<0.001) and diabetes (p=0.041) were additional predictors in the COVID-19 cohort, while lower albumin (p=0.002) was significant in the non-COVID-19 group. Excluding mortality, RRT and eGFR decline remained significant drivers of MAKE outcomes in the non-COVID-19 cohort.

CONCLUSIONS

Non-COVID-19 ARDS patients face a greater risk of MAKE-365 and adverse kidney outcomes due to higher RRT requirements and mortality rates. These findings underscore the importance of tailored interventions and long-term nephrology follow-up, particularly for patients with reduced eGFR, elevated bilirubin and comorbidities like diabetes and hypoalbuminaemia.

Для цитирования: Alenezi Faraj K, Mahida Rahul Y, Bangash Mansoor N, Patel Jaimin, Thickett David, Parekh Dhruv. Incidence of major adverse kidney events after ICU admission in COVID-19 and non-COVID-19 ARDS patients.. BMJ open. 2025. DOI: 10.1136/bmjopen-2024-094887.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.